MedPath

Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants

Completed
Conditions
Meconium Obstruction of Prematurity
Respiratory Distress Syndrome in Premature Infant
Registration Number
NCT03513640
Lead Sponsor
Seoul National University Hospital
Brief Summary

Although the pathophysiology of meconium obstruction of prematurity (MOP) is not clear, it is known that the decrease of the intestinal peristalsis due to decreased intestinal perfusion during antenatal or perinatal period. Recently, the level of citrulline has been used as an index of function and injury of the small intestine State. This study aimed to evaluate citrulline level of cord blood as a marker for early detection and observe changes in intestinal blood flow in MOP patient.

And We aimed to confirm the efficacy of the AT/ET ratio (ratio of the pulmonary artery time-to-peak velocity interval to the right ventricular ejection time) of the prenatal pulmonary artery as a noninvasive predictor of neonatal respiratory distress syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • premature infants born less than 34 weeks from mother with pregnancy induced hypertension, pre-eclampsia or eclampsia
Exclusion Criteria
  • major congenital anomalies
  • infants with hypotension while using inotropics

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of citrulline level between the meconium obstruction group and the normal feeding advance groupwithin 6 hours after birth

check the citrulline llevel from blood at birth

Comparison of prenatal AT/ET ratio of fetal pulmonary artery between respiratory distress syndrome group and the normal respiration groupwithin 10 days before delivery

Check the AT/ET ratio of fetal pulmonary artery within 10 days before birth

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath